However, though sclerostin levels may initially increase after SCI in response to mechanical unloading, in the long-term, circulating sclerostin may serve as a biomarker of osteoporosis severity and not a mediator of ongoing bone loss. The gene discussed is SOST; the disease is osteoporosis.